Physician profile
Fiona Blanco
NPI 1194768002
$6,059.59
in general payments reported to CMS, 2019-2025
23 companies · $885 in 2025
The $885 reported for 2025 was more than what 87% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $494 · 2020: $547 · 2021: $689 · 2022: $1,026 · 2023: $1,243 · 2024: $1,175 · 2025: $885.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,823 · Education: $480.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,822.77 |
| Education | $480.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $1,288.15 | 2020-2025 | Tremfya, Stelara, Simponi Aria |
| Leo Pharma INC. | $699.37 | 2020-2025 | Adbry |
| Genzyme Corporation | $574.87 | 2019-2025 | |
| Pfizer INC. | $563.06 | 2019-2025 | |
| Lilly USA, LLC | $462.26 | 2019-2024 | Taltz, Olumiant, Ebglyss |
| Abbvie INC. | $441.66 | 2019-2025 | Rinvoq, Skyrizi |
| Regeneron Healthcare Solutions, INC. | $309.68 | 2019-2025 | Dupixent |
| Sun Pharmaceutical Industries INC. | $265.99 | 2023-2025 | |
| E.R. Squibb & Sons, L.L.C. | $261.05 | 2022-2024 | Sotyktu |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $209.81 | 2020-2024 | Jublia, Arazlo, Duobrii |
| Amgen INC. | $168.87 | 2019-2022 | |
| Novartis Pharmaceuticals Corporation | $122.39 | 2019-2025 | |
| Galderma Laboratories, L.P. | $120.61 | 2020-2025 | Nemluvio |
| Dermavant Sciences, INC. | $112.88 | 2023-2024 | Vtama |
| Incyte Corporation | $105.65 | 2021-2025 | Opzelura |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $72.24 | 2020-2021 | |
| Almirall LLC | $70.96 | 2019-2022 | |
| Arcutis Biotherapeutics, INC. | $61.48 | 2023-2024 | Zoryve |
| Organon LLC | $48.67 | 2025 | Vtama, Nexplanon |
| Celgene Corporation | $48.42 | 2019 | |
| Sensus Healthcare, INC. | $19.00 | 2024 | |
| Dermira, INC. | $18.18 | 2020 | |
| Botanix Sb INC | $14.34 | 2025 | Sofdra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Fiona Blanco listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.